Brief analysis of the treatment methods of esophageal cancer: drug therapy

Drug treatment of esophageal cancer is one of the more common methods used to treat esophageal cancer. Many esophageal cancer patients will choose to treat esophageal cancer with drugs. Here are some common methods of drug treatment of esophageal cancer.

In general, the most common drugs used to treat esophageal cancer are:

1. Traditional Chinese medicine treatment currently adopts the main prescription plus syndrome differentiation and treatment, combining strengthening the body with promoting blood circulation and removing blood stasis. In North my country, Rubescens and Rubescensin are used. Experiments have shown that they have obvious cytotoxic effects on human esophageal squamous cell carcinoma cell line caes-17, and have a protective effect on a variety of animal transplanted tumors, which can achieve the purpose of treating esophageal cancer.

2. The cell proliferation cycle of esophageal cancer treated with chemotherapy is about 7 days, which is slightly longer than that of normal esophageal epithelial cells. Theoretically, its doubling time is about 10 days, so there are fewer proliferative cells and more non-proliferative cells. Therefore, although there are many chemical drugs used for esophageal cancer, there are not many that are really effective. The remission rate of single-drug chemotherapy is 15% to 20%, and the remission period is 1 to 4 months. Most combined chemotherapy uses a combined chemotherapy regimen based on DDP and BLM, with an effective rate of more than 30% and a remission period of about 6 months. Combined chemotherapy is not only used for advanced esophageal cancer, but also for comprehensive treatment with surgery and radiotherapy, which is very beneficial for the treatment of esophageal cancer. At present, the commonly used combined chemotherapy regimens in clinical practice include DDP-BLM, BLM-ADM, DDP-VDS-BML, and DDP-ADM-5-FU. Clinical observations have shown that chemotherapy drugs such as DDP, 5-FU and BLM have radiosensitizing effects. In the past decade, these chemotherapy drugs have been used as sensitizers in combination with radiotherapy to treat esophageal cancer, and have achieved encouraging results.

The above is an introduction to the common drugs for the treatment of esophageal cancer. I believe everyone has some understanding of this. For more questions about drugs for the treatment of esophageal cancer, you can consult our online experts, who will give you detailed answers.

For more information, please visit the esophageal cancer disease special topic at http://www..com.cn/zhongliu/sda/ or consult an expert for free. The expert will then give a detailed answer based on the patient's specific situation.